Characterization of Glioblastoma Cells Response to Regorafenib

SIMPLE SUMMARY: Glioblastoma is the most aggressive primary brain tumor, characterized by a short survival and by an invariably poor outcome. The clinical management of glioblastoma patients is based on surgery followed by adjuvant radio-chemotherapy. Glioblastoma therapy remained substantially unal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongiardi, Maria Patrizia, Buccarelli, Mariachiara, Formato, Alessia, Orecchini, Elisa, Salbini, Maria, Ricci, Valentina, Orsini, Tiziana, Putti, Sabrina, Chiesa, Silvia, Ricci-Vitiani, Lucia, D’Alessandris, Quintino Giorgio, Pallini, Roberto, Levi, Andrea, Falchetti, Maria Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777191/
https://www.ncbi.nlm.nih.gov/pubmed/36551679
http://dx.doi.org/10.3390/cancers14246193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777191/
https://www.ncbi.nlm.nih.gov/pubmed/36551679
http://dx.doi.org/10.3390/cancers14246193

Ejemplares similares